Skip Navigation

European Heart Journal 2000 21(19):1574-1583; doi:10.1053/euhj.1999.2207
Copyright © 2000 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (59)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Woods, A.
Right arrow Articles by Montgomery, H.E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Woods, A.
Right arrow Articles by Montgomery, H.E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Review

Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6

A. Woods, D.J. Brull, S.E. Humphriesf1 and H.E. Montgomery

Division of Cardiovascular Genetics, Department of Medicine, Royal Free and University College of London Medical School, The Rayne Institute, London, U.K.

revised October 12, 1999; accepted October 13, 1999

f1 Correspondence: Steve E. Humphries, PhD, MRCP, FRCPath, Division of Cardiovascular Genetics, Department of Medicine, Royal Free and UCL Medical School, The Rayne Institute, London, U.K.

References

  1. Ross R. Atherosclerosis—an inflammatory disease. N Engl J Med. 1998;340:115–126
  2. Kweider M, Lowe GDO, Murray GD, Kinane DF, McGavan DA. Dental disease, fibrinogen and white cell count; links with myocardial infarction? Scott Med J. 1993;38:73–74[ISI][Medline]
  3. Mattila KJ, Nieminen MS, Valtonen VV. Association between dental health and acute myocardial infarction. Br Med J. 1989;298:779–781[ISI][Medline]
  4. Panino K, Impivaara O, Tiekso J, Maki J. Missing teeth and ischaemic heart disease in men aged 54–64 years. Eur Heart J. 1993;14:54–56
  5. Beck J, Garcia R, Heiss G, Vokonas PS, Offenbacher S. Periodontal disease and cardiovascular risk. J Periodontol. 1996;67:1123–1137[ISI][Medline]
  6. Murray L, Bamford KB, O'Reilly DPJ, McGrum EE, Evans AE. Helicobacter pylori infection: relation with cardiovascular risk factors, ischaemic heart disease and social class. Br Heart J. 1995;74:497–501[Abstract/Free Full Text]
  7. Mendall MA, Goggin PM, Molineaux N. Relation of helicobacter pylori infection and coronary heart disease. Br Heart J. 1994;71:437–439[Abstract/Free Full Text]
  8. Whincup, PH, Mendall, MA, Perry, IJ, Strachan, DP, Walker, M, Prospective relations between Helicobacter pylori infection, coronary heart disease, and stroke in middle aged men, Heart, 1996, 75, 568, 72
  9. Saikku P, Leinonen M, Mattila K. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. 1988;2:983–986[ISI][Medline]
  10. Linnanmaki E, Leinonen M, Mattila K, Nieminen MS, Valtonen V, Saikku P. Chlamydia pneumoniae -specific circulating immune complexes in patients with chronic coronary heart disease. Circulation. 1993;87:1130–1134[Abstract/Free Full Text]
  11. Saikku P, Leinonen M, Tenkanen L. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med. 1992;116:273–278[ISI][Medline]
  12. Thom DH, Grayston JT, Siscovick DS, Wang SP, Weiss NS, Daling JR. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. J Am Med Assoc. 1992;268:68–72[Abstract]
  13. Grayston JT, Kuo CC, Coulson AS. Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation. 1995;92:3397–3400[Abstract/Free Full Text]
  14. Mendall MA, Carrington D, Strachan D. Chlamydia pneumoniae: risk factors for seropositivity and association with coronary heart disease. J Infect. 1995;30:121–128[CrossRef][ISI][Medline]
  15. Nieto FJ, Adam E, Sorlie P. Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-thickening, a measure of subclinical atherosclerosis. Circulation. 1996;94:922–927[Abstract/Free Full Text]
  16. Melnick JL, Adam E, DeBakey MM. Cytomegalovirus and atherosclerosis. Eur Heart J. 1993;14:30–38
  17. Wick G, Schett G, Auberger A, Kleindienst R, Zu Q. Is atherosclerosis an immunologically mediated disease? Immunol Today. 1995;16:27–33[CrossRef][ISI][Medline]
  18. Fogari R, Zoppi A, Marasi G, Vanasia A, Villa G. Associations between plasma fibrinogen levels and cardiovascular risk factors in hypertensive men. J Cardiovasc Risk. 1994;1:341–345[CrossRef][Medline]
  19. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC. C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. Br Med J. 1996;312:1049–1050[Free Full Text]
  20. Rosengren A, Wilhelmsen L, Welin T, Tsipogianni A, Teger-Nilsson AC, Wedel H. Social influences and cardiovascular risk factors as determinants of plasma fibrinogen concentration in a general population sample of middle aged man. Br Med J. 1990;300:634–638[ISI][Medline]
  21. de Maat MP, Pietersma A, Kofflard M, Sluiter W, Kluft C. Association of plasma fibrinogen levels with coronary artery disease, smoking and inflammatory markers. Atherosclerosis. 1996;121:185–191[CrossRef][ISI][Medline]
  22. Lee AJ, Smith WCS, Lowe GDO, Tunstall-Pedoe H. Plasma fibrinogen and coronary risk factors: The Scottish Heart Health Study. J Clin Epidemiol. 1990;9:913–919
  23. Meade TW. Risks and mechanisms of cardiovascular events in users of oral contraceptives. Am J Obstet Gynecol. 1988;158:1646–1652[ISI][Medline]
  24. Robinson GE, Burren T, Mackie IJ. Changes in haemostasis after stopping the combined contraceptive pill: implications for major surgery. Br Med J. 1991;302:269–271[ISI][Medline]
  25. David JL, Gaspard UJ, Gillian D, Raskinet R, Leopt MR. Hemostasis profile in women taking low dose oral contraceptives. Am J Obstet Gynecol. 1990;163:1–5[ISI][Medline]
  26. Goldzieher JW. Hormonal contraception, benefits versus risk. Am J Obstet Gynecol. 1987;:1023–1028
  27. Ernst E. Oral contraceptives, fibrinogen and cardiovascular risk. Atherosclerosis. 1992;93:1–5[CrossRef][ISI][Medline]
  28. Montgomery HE, Clarkson P, Nwose OM. The acute rise in plasma fibrinogen concentration with exercise is influenced by the G-453-polymorphism of the beta-fibrinogen gene. Arterioscler Thromb Vasc Biol. 1996;16:386–391[Abstract/Free Full Text]
  29. Mittleman MA, Maclure M, Tofler GH, Sherwood JB, Goldberg RJ, Muller JE. Triggering of acute myocardial infarction by heavy physical exertion. Protection against triggering by regular exertion. N Engl J Med. 1993;329:1678–1683
  30. Willich SN, Lewis M, Lowel H, Arntz H-R, Schubert F, Schroder R. Physical exertion as a trigger of acute myocardial infarction. N Engl J Med. 1993;329:1684–1690[Abstract/Free Full Text]
  31. Housley E, Leng GC, Donnan PT, Fowkes FGR. Physical activity and risk of peripheral arterial disease in the general population: Edinburgh Artery Study. J Epidemiol Community Health. 1993;47:475–480[Abstract]
  32. Stratton JR, Chandler WL, Schwartz RS. Effects of physical conditioning on fibrinolytic variables and fibrinogen in young and old healthy adults. Circulation. 1991;83:1692–1697[Abstract/Free Full Text]
  33. Rankinen T, Rauramaa R, Vaisanen S. Inverse relationship between physical activity and plasma fibrinogen in postmenopausal women. Atherosclerosis. 1993;102:181–186[CrossRef][ISI][Medline]
  34. Morris JN, Clayton DG, Everitt MG, Semmence AM, Burgess EH. Exercise in leisure time: coronary attack and death rate. Br Heart J. 1990;63:325–334[Abstract/Free Full Text]
  35. Slattery ML, Jacobs DR, Nichaman MZ. Leisure time physical activity and coronary heart disease: the US railroad Study. Circulation. 1989;79:304–311[Abstract/Free Full Text]
  36. Morris JN, Adam C, Chave SPW, Siney C, Epstein L, Sheehan DJ. Vigorous exercise in leisure time and the incidence of coronary heart disease. Lancet. 1976;:336–339
  37. Shinton R, Sagar G. Lifelong exercise and stroke. Br Med J. 1993;307:231–234[ISI][Medline]
  38. Wannamethee G, Shaper AG. Physical activity and stroke in British middle aged men. Br Med J. 1992;304:597–601[ISI][Medline]
  39. Slattery ML, Jacobs DR. Physical fitness and cardiovascular disease mortality: the US Railroad Study. Am J Epidemiol. 1988;127:571–580[Abstract/Free Full Text]
  40. Paffenbarger RS, Hyde RT, Wing AL, Hsieh C. Physical activity, all-cause mortality, and longevity of college alumni. N Engl J Med. 1986;314:605–613[Abstract]
  41. Berlin JA, Colditz GA. A meta-analysis of physical activity in the prevention of coronary heart disease. Am J Epidemiol. 1990;132:612–628[Abstract/Free Full Text]
  42. Stampfer MJ, Colditz GA, Willett WC. Postmenopausal estrogen therapy and cardiovascular disease: ten-year followup from the Nurse's Health Study. N Engl J Med. 1991;273:199–208
  43. J Am Med Assoc. 1995;273:199–208[Abstract]
  44. Fowkes FGR, Pell JP, Donnan PT. Sex differences in susceptibility to etiologic factors for peripheral atherosclerosis. Importance of plasma fibrinogen and blood viscosity. Arterioscler Thromb. 1994;14:862–868[Abstract/Free Full Text]
  45. Mori T, Sasaki J, Kawaguchi H. Serum glycoproteins and severity of coronary atherosclerosis. Am Heart J. 1995;129:234–238[CrossRef][ISI][Medline]
  46. Lassila R, Pltonen S, Lepantalo M, Saarinen O, Kauhanen P, Manninen V. Severity of peripheral atherosclerosis is associated with fibrinogen and degradation of cross-linked fibrin. Arterioscler Thromb. 1993;13:1738–1742[Abstract/Free Full Text]
  47. Heinrich J, Schulte H, Schonfeld R, Kohler E, Assmann G. Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain. Thromb Haemost. 1995;73:374–379[ISI][Medline]
  48. Berk BC, Weintraub WS, Alexander RW. Elevation of C-reactive protein in ‘active’ coronary artery disease. Am J Cardiol. 1990;65:168–172[CrossRef][ISI][Medline]
  49. Kohchi K, Takebayashi S, Hiroki T, Nobuyoshi M. Significance of adventitial inflammation of the coronary artery in patients with unstable angina: results of autopsy. Circulation. 1985;71:709–716[Abstract/Free Full Text]
  50. Liuzzo G, Biasucci LM, Rebuzzi AG. Plasma protein acute phase response in unstable angina is not induced by ischemic injury. Circulation. 1996;94:2372–2380
  51. Ridker PM, Cushman M, Stampfer MJ, Tracey RP, Hennekens CH. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973–979[Abstract/Free Full Text]
  52. Haverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MB. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet. 1997;349:462–466[CrossRef][ISI][Medline]
  53. Yarnell JW, Baker IA, Sweetnam PM. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischaemic heart disease. The Caerphilly and Speedwell Collaborative Heart Disease Studies. Circulation. 1991;83:836–844[Abstract/Free Full Text]
  54. Resch K, Ernst E, Matrai A, Paulsen H. Fibrinogen and viscosity as risk factors for subsequent cardiovascular events in stroke survivors. Ann Int Med. 1992;117:371–375[ISI][Medline]
  55. Kannel WB, Wolf PA, Catelli WP, D'Agostino RB. Fibrinogen and risk of cardiovascular disease. The Framingham Study. J Am Med Assoc. 1987;258:1183–1186[Abstract]
  56. Stone MC, Thorp JM. Plasma fibrinogen—a major coronary risk factor. J R Coll Gen Pract. 1985;35:565–569[ISI][Medline]
  57. Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ. Fibrinolytic activity, clotting factors and long term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet. 1993;342:1076–1079[CrossRef][ISI][Medline]
  58. Meade TW, Mellows S, Brozovic M. Hemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet. 1986;2:533–537[ISI][Medline]
  59. Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med. 1984;311:501–505[Abstract]
  60. Tracy RP, Lemaitre RN, Psaty BM. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the cardiovascular Health Study and the Rural health Promotion project. Arterioscler Thromb Vasc Biol. 1997;17:1121–1127[Abstract/Free Full Text]
  61. Ernst E, Resch KL. Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med. 1993;118:956–963[Abstract/Free Full Text]
  62. Kishimoto T. The biology of interleukin-6. Blood. 1989;71:1–10
  63. Castell JV, Gomez-Lechon MJ, David M. Interleukin- is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett. 1989;24:237–239
  64. Harris TB, Ferrucci L, Tracy RP. Mortality risk associated with elevated interleukin-6 and C-reactive protein in old age. Am J Med. 1999;106:506–512[CrossRef][ISI][Medline]
  65. Biasucci LM, Vitelli A, Liuzzo G. Elevated levels of IL-6 in unstable angina. Circulation. 1996;94:874–877[Abstract/Free Full Text]
  66. Biasucci LM, Liuzzo G, Grillo RL. Elevated levels of C-reactive protein at discharge predicts recurrent instability in patients with unstable angina. Circulation. 1999;99:855–860[Abstract/Free Full Text]
  67. Biasucci LM, Liuzzo G, Fantuzzi G. Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events. Circulation. 1999;88:2079–2084
  68. Bataille R, Klein B. C-reactive protein levels as a direct indictor of interleukin-6 levels in humans in vivo. Arthritis Rheum. 1992;35:982–983[ISI][Medline]
  69. Tappia PS, Troughton KL, Langley-Evans SC, Grimble RF. Cigarette smoking influences cytokine production and anti-oxidant defenses. Clin Sci. 1995;88:485–489[Medline]
  70. Northoff H, Weinstock C, Berg A. The cytokine response to strenuous exercise. Int J Sports Med. 1994;15:S167–S171
  71. Zhou D, Kusnecov AW, Shurin MR, DePaoli M, Rabin BS. Exposure to physical and psychological stressors elevates plasma interleukin-6: relationship to the activation of the hypothalamic-pituitary-adrenal axis. Endocrinology. 1993;133:2523–2530[Abstract]
  72. Maes M, Song C, Lin A. The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. Cytokine. 1998;10:313–318[CrossRef][ISI][Medline]
  73. Song C, Kenis G, van Gastel A. Influence of psychological stress on immune-inflammatory variables in normal humans. Part II. Altered serum concentrations of natural anti-inflammatory agents and soluble membrane antigens of monocytes and T lymphocytes. Psychiatry Res. 1999;85:293–303[CrossRef][ISI][Medline]
  74. Marmot MG, Shipley MJ, Rose G. Inequalities in death-specific explanations of a general pattern? Lancet. 1984;00:1003–1006
  75. Brunner EJ, Marmot MG, Nanchahal K. Social inequality in coronary risk: central obesity and the metabolic syndrome: evidence from the Whitehall II Study. Diabetologia. 1997;40:1341–1349[CrossRef][ISI][Medline]
  76. Fishman D, Faulds G, Humphries S, Woo P. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. JCI. 1998;102:1369–1372[ISI][Medline]
  77. Humphries, SE, Faulds, G, Mohamed-Ali, V, Luong, LA, Woo, P, Hamsten, A, A common polymorphism in the promotor region of the interleukin-6 (G-176-C) is strongly protective against myocardial infarction at a young age, 1999
  78. Ernst E. Some basic facts about fibrinogen—an introduction. Ernst E, Koenig W, Lowe GDO, Meade TW. Fibrinogen: ‘a new’ cardiovascular risk factor. : Blackwell-MSV; 1992.
  79. Dalmon J, Laurent M, Courtois G. The human beta fibrinogen promotor contains a hepatocyte nuclear factor 1-dependent interleukin-6-responsive element. Mol Cell Biol. 1993;13:1183–1193[Abstract/Free Full Text]
  80. Zhang JZ, Redman CM. Identification of ß-chain domains involved in human fibrinogen assembly. J Biol Chem. 1992;267:21727–21732[Abstract/Free Full Text]
  81. Roy SN, Mukhopadhyay G, Redman CM. Regulation of fibrinogen assembly: transfection of hep G2 cells with ß-cDNA specifically enhances synthesis of the three component chains of fibrinogen. J Biol Chem. 1990;265:6389–6393[Abstract/Free Full Text]
  82. Humphries SE, Ye S, Talmud P, Bara L, Wilhelmsen L, Tiret L. European Atherosclerosis Research Study: genotype at the fibrinogen Locus (G455-A beta-gene) is associated with differences in plasma fibrinogen levels in young men and women from different regions in Europe. Evidence for gender-genotype-environment interaction. Arterioscler Thromb Vasc Biol. 1995;15:96–104[Abstract/Free Full Text]
  83. Iso H, Folsom AR, Winkelmann JC. Polymorphisms of the beta fibrinogen gene and plasma fibrinogen concentration in Caucasian and Japanese population samples. Thromb Haemost. 1995;73:
  84. Thomas AE, Green FR, Kelleher CH. Variation in the promotor region of the ß-fibrinogen gene is associated with plasma fibrinogen levels in smokers and non-smokers. Thrombosis Haemostasis. 1991;65:487–490[ISI][Medline]
  85. Heinrich J, Funke H, Rust S. Impact of polymorphisms in the alpha- and beta-fibrinogen gene on plasma fibrinogen concentrations of coronary heart disease patients. Thromb Res. 1995;77:209–215[CrossRef][ISI][Medline]
  86. Scarabin P-Y, Bara L, Ricard S. Genetic variation at the ß-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction. Arterioscler Thromb. 1993;13:886–891[Abstract/Free Full Text]
  87. Shea, S, Isasi, CR, Couch, S, Relationships of the G–455A mutation in the ß-fibrinogen promoter, family history of ischaemic heart disease and obesity to plasma fibrinogen levels in children: the Columbia Biomarkers Study
  88. Fowkes FGR, Connor JM, Smith FB, Wood J, Donnan PT, Lowe GDO. Fibrinogen genotype and risk of peripheral atherosclerosis. Lancet. 1992;339:693–696[CrossRef][ISI][Medline]
  89. Thomas A, Lamlum H, Humphries S, Green F. Linkage disequilibrium across the fibrinogen locus as shown by five genetic polymorphisms, G/A–455 (HaeIII), C/T–148 (Hind III/Alu), T/G+1689 (Ava II) and BcII (ß-fibrinogen) and TaqI ({alpha}-fibrinogen) and their detection by PCR. Hum Mutat. 1994;3:79–81[CrossRef][ISI][Medline]
  90. Baumann RE, Henschen AH. Linkage disequilibrium relationships among four polymorphisms within the human fibrinogen gene cluster. Hum Genet. 1994;94:165–170[ISI][Medline]
  91. Quizilbash N, Jones L, Warlow C, Mann J. Fibrinogen and lipid concentrations as risk factors for transient ischaemic attacks and minor ischaemic strokes. Br Med J. 1991;303:605–609[ISI][Medline]
  92. Meade TW, Imeson J, Stirling Y. Effects of changes in smoking and other characteristics on clotting factors and the risk of disease. Lancet. 1987;ii:986–988
  93. Pyke SD, Thompson SG, Buchwalsky R, Kienast J. Variability over time of haemostatic and other cardiovascular risk factors in patients suffering from angina pectoris. Thromb Haemostas. 1993;70:743–746[ISI][Medline]
  94. Errill EW. Physiol Rev Rheology Blood. 1969;49:863–888
  95. Watanabe K, Tanaka K. Influence of fibrin, fibrinogen and fibrinogen degradation products on cultures endothelial cells. Atherosclerosis. 1983;48:57–70[CrossRef][ISI][Medline]
  96. Ishida T, Tanaka K. Effects of fibrin and fibrinogen-degradation products on the growth of rabbit aortic smooth muscle cells in culture. Atherosclerosis. 1982;44:161–174[CrossRef][ISI][Medline]
  97. Packham MA, Mustard JF. Platelet adhesion. Prog Hemost Thromb. 1984;7:211–288[ISI][Medline]
  98. Oleksowicz L, Mrowiec Z, Zuckerman D, Isaacs R, Dutcher J, Puszkin E. Platelet activation induced by interleukin-6: evidence for a mechanism involving arachadonic acid metabolism. Thromb Haemost. 1994;72:302–308[ISI][Medline]
  99. Nawroth PP, Handley D, Stern DM. The multiple levels of endothelial cell-coagulation factor interactions. Clin Haematol. 1986;151:293–321
  100. Bhagat K, Vallance P. Infection, inflammation and infarction: does acute endothelial dysfunction provide a link? Lancet. 1997;349:1391–1392[CrossRef][ISI][Medline]
  101. Romano M, Sironi M, Toniatti C. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity. 1997;6:1–20[CrossRef][ISI][Medline]
  102. Dustin ML, Rothlein R, Bhan AK, Dinarelle CA, Springer TA. Induction by IL-1 and interferon-{gamma}: tissue distribution, biochemistry and function of a natural adherence molecule (ICAM-1). J Immunol. 1986;137:245–254[Abstract]
  103. Hawrylowicz CM, Howells GL, Feldmann M. Platelet-derived interleukin-1 induces human endothelial adhesion molecule expression and cytokine production. J Exp Med. 1991;174:783–790
  104. DeGraba TJ. Expression of inflammatory mediators and adhesion molecules in human atherosclerotic plaques. Neurology. 1997;49:S15–S19[CrossRef][ISI][Medline]
  105. Haught WH, Mansour M, Rothlein R. Alterations in circulating intercellular adhesion molecule-1 and L-selectin: further evidence for chronic inflammation in ischaemic heart disease. Am Heart J. 1996;13:1–8
  106. Mohamed-Ali V, Goodrick S, Rawesh. Subcutaneous adipose tissue releases interluekin-6, but not tumour necrosis factor-{alpha}, in vivo. J Clin Endocrinol Metab. 1997;82:4196–4200[Abstract/Free Full Text]
  107. Steinberg D, Wiztum JL. Lipoproteins and atherogenesis: current concepts. J Am Med Assoc. 1990;132:1–8
  108. Greenberg AS, Nordan RP, McIntosh J, Calvo JC, Scow RP, Jablons D. Interluekin-6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: a possible role for interleukin-6 in cancer cachexia. Cancer Res. 1992;52:4113–4116[Abstract/Free Full Text]
  109. Pesonen E, Rapola J, Vikari J, Turtinen J, Akerbom HK. Altered serum lipid profile after systemic infection in children: risk factor for CHD? Eur Heart J. 1993;14:7–11
  110. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol. 1999;19:972–978[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 CirculationHome page
J. Dai, A. H. Miller, J. D. Bremner, J. Goldberg, L. Jones, L. Shallenberger, R. Buckham, N. V. Murrah, E. Veledar, P. W. Wilson, et al.
Adherence to the Mediterranean Diet Is Inversely Associated With Circulating Interleukin-6 Among Middle-Aged Men: A Twin Study
Circulation, January 15, 2008; 117(2): 169 - 175.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
E. Esteve, A. Castro, A. Lopez-Bermejo, J. Vendrell, W. Ricart, and J.-M. Fernandez-Real
Serum Interleukin-6 Correlates With Endothelial Dysfunction in Healthy Men Independently of Insulin Sensitivity
Diabetes Care, April 1, 2007; 30(4): 939 - 945.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
A. Csiszar, K. Smith, N. Labinskyy, Z. Orosz, A. Rivera, and Z. Ungvari
Resveratrol attenuates TNF-{alpha}-induced activation of coronary arterial endothelial cells: role of NF-{kappa}B inhibition.
Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1694 - H1699.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
A. Tedgui and Z. Mallat
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Physiol Rev, April 1, 2006; 86(2): 515 - 581.
[Abstract] [Full Text] [PDF]

Home page
 Psychosom. Med.Home page
J. M. McCaffery, N. Frasure-Smith, M.-P. Dube, P. Theroux, G. A. Rouleau, Q. Duan, and F. Lesperance
Common genetic vulnerability to depressive symptoms and coronary artery disease: a review and development of candidate genes related to inflammation and serotonin.
Psychosom Med, March 1, 2006; 68(2): 187 - 200.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
E. J. Armstrong, D. A. Morrow, and M. S. Sabatine
Inflammatory Biomarkers in Acute Coronary Syndromes: Part I: Introduction and Cytokines
Circulation, February 14, 2006; 113(6): e72 - e75.
[Full Text] [PDF]

Home page
 ChestHome page
O. Appoloni, E. Dupont, M. Vandercruys, M. Andrien, J. Duchateau, and J.-L. Vincent
Association Between the TNF-2 Allele and a Better Survival in Cardiogenic Shock
Chest, June 1, 2004; 125(6): 2232 - 2237.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
H. Yamagami, K. Kitagawa, Y. Nagai, H. Hougaku, M. Sakaguchi, K. Kuwabara, K. Kondo, T. Masuyama, M. Matsumoto, and M. Hori
Higher Levels of Interleukin-6 Are Associated With Lower Echogenicity of Carotid Artery Plaques
Stroke, March 1, 2004; 35(3): 677 - 681.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
M. Huang, X. Pang, K. Karalis, and T. C. Theoharides
Stress-induced interleukin-6 release in mice is mast cell-dependent and more pronounced in Apolipoprotein E knockout mice
Cardiovasc Res, July 1, 2003; 59(1): 241 - 249.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
J. M. Fernandez-Real and W. Ricart
Insulin Resistance and Chronic Cardiovascular Inflammatory Syndrome
Endocr. Rev., June 1, 2003; 24(3): 278 - 301.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Coll. Nutr.Home page
A. P. Simopoulos
Omega-3 Fatty Acids in Inflammation and Autoimmune Diseases
J. Am. Coll. Nutr., December 1, 2002; 21(6): 495 - 505.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
E. A. Bermudez, N. Rifai, J. Buring, J. E. Manson, and P. M. Ridker
Interrelationships Among Circulating Interleukin-6, C-Reactive Protein, and Traditional Cardiovascular Risk Factors in Women
Arterioscler. Thromb. Vasc. Biol., October 1, 2002; 22(10): 1668 - 1673.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
F Andreotti, I Porto, F Crea, and A Maseri
Inflammatory gene polymorphisms and ischaemic heart disease: review of population association studies
Heart, February 1, 2002; 87(2): 107 - 112.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
E. Lindmark, E. Diderholm, L. Wallentin, and A. Siegbahn
Relationship Between Interleukin 6 and Mortality in Patients With Unstable Coronary Artery Disease: Effects of an Early Invasive or Noninvasive Strategy
JAMA, November 7, 2001; 286(17): 2107 - 2113.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
H.J. Koch and C. Raschka
Over-training syndrome as a model of a coronary inflammation process?
Eur. Heart J., August 2, 2001; 22(16): 1512 - 1512.
[PDF]

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (59)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Woods, A.
Right arrow Articles by Montgomery, H.E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Woods, A.
Right arrow Articles by Montgomery, H.E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?